F. Öhrn

发表

Optimal group-sequential designs for simultaneous testing of superiority and non-inferiority.

Christopher Jennison, C. Jennison, F. Öhrn, 2010, Statistics in medicine.

New Product Development in an International Setting The Use of Information and Communication Technology and the Impact of Cultural Differences

F. Öhrn, Karoline Thumm, 2007 .

Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial

Sanjiv J. Shah, D. DeMets, S. Solomon, 2021, European journal of heart failure.

Prevalence of Viremic hepatitis C, hepatitis B, and HIV infection, and vaccination status among prisoners in Stockholm County

A. Duberg, K. Lindahl, F. Öhrn, 2019, BMC Infectious Diseases.

Statistical and practical considerations in designing of immuno-oncology trials

A. Stone, F. Öhrn, P. Mukhopadhyay, 2020, Journal of biopharmaceutical statistics.

Nonproportional Hazards for Time-to-Event Outcomes in Clinical Trials: JACC Review Topic of the Week.

L. Sharples, S. Pocock, G. Stone, 2019, Journal of the American College of Cardiology.

Improved group sequential Holm procedures for testing multiple correlated hypotheses over time

C. Burman, F. Öhrn, Julia Niewczas, 2021, Journal of biopharmaceutical statistics.

Non-proportional Hazards for Time-to-event Outcomes in Clinical Trials: A practical guide to analysis strategies

C. Burman, F. Öhrn, Gregg W. Stone, 2019 .

Optimal group‐sequential designs for simultaneous testing of superiority and non‐inferiority

C. Jennison, F. Öhrn, 2010, Statistics in medicine.